Cancer Cured For Good

[Guest guest]

Cancer Cured For Good

_http://www.thenhf.com/articles/articles_792/articles_792.htm_

(http://www.thenhf.com/articles/articles_792/articles_792.htm)

By Bill Sardi and Timothy Hubbell

October 2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

It works 100% of the time to eradicate cancer completely, and cancer does

not recur even years later. That is how researchers describe the most

convincing cancer cure ever announced.

 

The weekly injection of just 100 billionths of a gram of a harmless

glyco-protein (a naturally-produced molecule with a sugar component and a

protein

component) activates the human immune system and cures cancer for good,

according to human studies among breast cancer and colon cancer patients,

producing

complete remissions lasting 4 and 7 years respectively. This glyco-protein

cure is totally without side effect but currently goes unused by cancer

doctors.

 

 

Normal Gc protein (also called Vitamin-D binding protein) , an abundant

glyco-protein found in human blood serum, becomes the molecular switch to

activate macrophages when it is converted to its active form, called Gc

macrophage

activating factor (Gc-MAF). Gc protein is normally activated by conversion to

Gc-MAF with the help of the B and T cells (bone marrow-made and thymus

gland-made white blood cells). But, as researchers explain it themselves,

cancer

cells secrete an enzyme known as alpha-N-acetylgalactosaminidase (also called

Nagalase) that completely blocks conversion of Gc protein to Gc-MAF,

preventing tumor-cell killing by the macrophages. This is the way cancer cells

escape

detection and destruction, by disengaging the human immune system. This also

leaves cancer patients prone to infections and many then succumb to pneumonia

or other infections.

 

The once-weekly injection of minute amounts of Gc-MAF, just 100 nanograms

(billionths of a gram), activates macrophages and allows the immune system to

pursue cancer cells with vigor, sufficient to produce total long-term cures in

humans.

 

Nobuto Yamamoto, director of the Division of Cancer Immunology and Molecular

Biology, Socrates Institute for Therapeutic Immunology, Philadelphia,

Pennsylvania, says this is “probably the most potent macrophage activating

factor

ever discovered.â€

 

 

A MACROPHAGE OVERCOMES AND EATS A CANCER CELL.

FROM THE UPJOHN COMPANY, THE IMMUNE SYSTEM

 

Once a sufficient number of activated macrophages are produced, another

Gc-MAF injection is not needed for a week because macrophages have a half-life

of

about six days. After 16-22 weekly doses of Gc-MAF the amount of Nagalase

enzyme fell to levels found in healthy people, which serves as evidence tumors

have been completely eliminated. The treatment was fool-proof - - - it worked

in 100% of 16 breast cancer patients and there were no recurrent tumors over

a period of 4 years, says a report in the January 15 issue of the

International Journal of Cancer. [international Journal Cancer.2008 January15;

122(2):461-7]

 

In another startling follow-up report by Dr. Yamamoto and colleagues,

published in the upcoming July issue of Cancer Immunology Immunotherapy, Gc-MAF

therapy totally abolished tumors in 8 colon cancer patients who had already

undergone surgery but still exhibited circulating cancer cells (metastases).

After 32-50 weekly injections, â€all colorectal cancer patients exhibited

healthy

control levels of the serum Nagalase activity, indicating eradication of

metastatic tumor cells,â€said researchers, an effect that lasted 7 years with

no

indication of cancer recurrence either by enzyme activity or CT scans, said

researchers. [Cancer Immunology, Immunotherapy Volume 57, Number 7 / July 2008]

Published in an early online edition of this journal, this confirming report

has received no attention by the new media so far, despite its striking

importance.

 

Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr.

Yamamoto first described this immuno-therapy in 1993. [The Journal of

Immunology,

1993 151 (5); 2794-2802]

 

In a similar animal experiment published in 2003, researchers in Germany,

Japan and the United States collaborated to successfully demonstrate that after

they had injected macrophage activating factor (Gc-MAF) into tumor-bearing

mice, it totally eradicated tumors. [Neoplasia 2003 January; 5(1): 32–40]

 

In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice, with

the same startling results. A single enzyme injection doubled the survival of

these mice and just four enzyme injections increased survival by 6-fold.

[Cancer Research 1997 Jun 1; 57(11):2187-92]

 

In 1996 Dr. Yamamoto reported that all 52 cancer patients he had studied

carried elevated blood plasma levels of the immune inactivating

alpha-N-acetylgalactosaminidase enzyme (Nagalase), whereas healthy humans had

very low levels

of this enzyme. [Cancer Research 1996 Jun 15; 56(12):2827-31]

 

In the early 1990s, Dr. Yamamoto first described how the human immune system

is disengaged by enzymes secreted from cancer cells, even filing a patent on

the proposed therapy. [uS Patent 5326749, July 1994; Cancer Research 1996

June 15; 56: 2827-31]

 

Activated Gc protein has been used in humans at much higher doses without

side effects. This Gc macrophage activating factor (Gc-MAF) has been shown to

be effective against a variety of cancers including breast, prostate, stomach,

liver, lung, uterus, ovary, brain, skin, head/neck cancer, and leukemia.

 

Although GcMAF is also called Vitamin-D binding protein, the activation of

macrophages does not require Vitamin D.

 

It cannot be said the Gc-MAF cancer cure has gone unheralded. Reuters News

covered this developing story in January. But the news story still did not

receive top billing nor did it fully elucidate the importance of the discovery,

actually made years ago, that the human body is capable of abolishing cancer

once its immune system is properly activated.

 

GcMAF is a naturally made molecule and is not patentable, though its

manufacturing process is patent protected. There is no evidence of any current

effort to commercialize this therapy or put it into practice. Should such an

effective treatment for cancer come into common practice, the income stream from

health-insurance plans for every oncology office and cancer center in the world

Would likely be reduced to the point of financial insolvency and hundreds of

thousands of jobs would be eliminated.

 

The National Cancer Institute estimates cancer care in the U.S. costs ~$72

billion annually (2004). Furthermore, about $55 billion of cancer drugs are

used annually, none which have not significantly improved survival rates

throughout the history of their use. If a typical cancer patient had to undergo

30

GcMAF injections at a cost of $150 per injection, that would cost ~$4500, not

counting doctor’s office visits and follow-up testing. For comparison,

gene-targeted cancer drugs range from $13,000 to $100,000 in cost per year and

produce only marginal improvements in survival (weeks to months). [Targeted

Oncology 2007 April, 2 (2); 113-19]

 

Up to this point, the National Cancer Institute is totally silent on this

discovery and there is no evidence the cancer care industry plans to quickly

mobilize to use this otherwise harmless treatment.

 

- - -

 

Addendum: Sadly, the treatment you have just read about is not available

anywhere. Its inventor is attempting to patent a version of it to profiteer off

of it even though there is no need to improve upon the GcMAF molecule - - it

worked without failure to completely cure four different types of cancer with

no long-term remissions and without side effect. While GcMAF is produced by

every healthy adult, there are no centers available to extract it from blood

samples and inject it into patients with malignancies. Hopefully, someday,

doctors will write protocols to do this and submit them to institutional review

boards so GcMAF treatment can be performed on an experimental basis. GcMAF

is a naturally-made molecule that cannot be patented. This article was written

to reveal that there are proven cancer cures that go unused. Of interest,

not one oncologist has requested information about GcMAF since this article was

written, while I have been barraged with inquires from cancer patients,

their families and some interested physicians who are not cancer doctors. -Bill

Sardi

 

- - -

 

Based in Southern California, Bill Sardi is a notedand well-known author,

lecturer, speaker, and health researcher, with numerous books and articles to

his credit. He can be reached at _BSardi_ (BSardi) .

Timothy Hubbell, a biochemist from Cincinnati, first called attention to this

discovery and provided consultation on the biochemistry.

 

- - -

 

Help NHF get the word out about GcMAF and other proven cures for cancer that

are being ignored. Learn how NHF is the leading health freedom organization,

for example, battling for your right to maintain access to dietary

supplements without restrictions imposed by quasi-governing bodies like CODEX

and our

other missions. Search the NHF website for more helpful information and

become a member by _clicking here_ (http://www.thenhf.com/join_the_nhf.html) .